Metabolomics

Metabolomics provides support for innovative metabolism-related research by providing the technological infrastructure and expertise required to comprehensively assess the complex metabolic landscape of biological samples.

Services include:

• Single and double mode liquid chromatography-mass spectrometry (LC-MS)
• Triple quad single mode LC-MS
• Basic and advanced data analysis

For additional information about equipment and services, see the UR Metabolomics Resource.

Leadership

Bradley Smith, PhD
Research Assistant Professor of Biochemistry and Biophysics

Joshua Munger, PhD
Professor of Biochemistry and Biophysics
Professor of Microbiology and Immunology

NCI Designation and Acknowledging the CCSG

The National Cancer Institute (NCI) has designated the University of Rochester Medicine Wilmot Cancer Institute as the nation’s 73rd cancer center. Communicating the outcomes of NIH-funded projects and the role of NIH support in biomedical research enhances public understanding of how we, as a research community, are working to improve human health.  To properly acknowledge the Cancer Center Support Grant (CCSG) in your work which utilized the Shared Resources since March 15th, 2025, please include the following statement in the acknowledgement section of your publication(s):

“The work described in this publication benefited from the support of the Metabolomics Shared Resource at the Wilmot Cancer Institute, supported in part by the University of Rochester Medicine Wilmot Cancer Institute Support Grant #P30CA272302. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

Importantly, Wilmot members should use our CCSG Shared Resource terminology to acknowledge the cores in publications, presentations, and grants.  Therefore,

• Instead of Metabolomics Resource, use Metabolomics Shared Resource.